Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Longitudinal Minimally Invasive Dental Caries Protocols in Brazilian Schoolchildren

Official title: Longitudinal Evaluation of Minimally Invasive Protocols for the Prevention and Control of Dental Caries in Brazilian Schoolchildren: A Multicenter Study Protocol

Run by University of Nove de Julho · NCT06999005 · Data updated 2026-11-12

This study tests minimally invasive dental treatments for active caries in 6–12 year-olds in Brazilian public schools to see if these approaches prevent progression over 24 months.

More Dental Caries trials

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment2500 (estimated)
SponsorUniversity of Nove de Julho
Academic / other
Locations1 site (Santos, São Paulo)
StatusRecruiting
StartedFebruary 28, 2026
Main results expectedFebruary 2028
Study endsDecember 2028
Registry record updatedMay 15, 2026
Trial IDNCT06999005 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6–12 with at least one erupted permanent first molar and active caries (ICDAS 1–6) who can attend quarterly visits for 24 months.

Probably not a fit

Children without active caries or those unable to attend regular follow-ups may not experience benefit from the treatment protocols.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, pragmatic interventional study in five Brazilian cities evaluates minimally invasive protocols for prevention and management of dental caries among schoolchildren in routine public health settings. In phase one, 50,000 children receive screening with ICDAS and receive preventive measures and education, including fluoride varnish and supervised brushing. In phase two, 2,500 children with active caries are treated using ICDAS-based approaches such as fluoride varnish, ART sealants, and ART restorations, with quarterly follow-ups for up to two years. The study is non-randomized and coordinated by ABOPED with lead involvement from the University of Nove de Julho, aiming to observe lesion behavior and protocol performance in real-world school health programs.

Why it matters

Potential benefit: If successful, the protocols could reduce caries progression and improve oral health outcomes for schoolchildren in public health settings.

How similar studies have gone: Prior studies have shown potential for minimally invasive approaches in caries management, but this study is conducted in routine public-school settings and is broader in scope.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children aged between 6 and 12 years at the time of enrollment
* Presence of at least one erupted permanent first molar
* Diagnosis of active caries lesions classified according to ICDAS (scores 1 to 6)
* Written informed consent signed by a legal guardian and assent signed by the child
* Ability to attend quarterly follow-up visits over a 24-month period

Exclusion Criteria:

* Children requiring endodontic treatment or presenting extensive pulpal involvement
* Presence of systemic diseases or medical conditions that contraindicate dental care
* Known allergy to any material used in the study (fluoride varnish, high-viscosity glass ionomer cement)
* Participation in other clinical dental studies that could interfere with the outcomes

Where it's running

  • Universidade Metropolitana de Santos - UNIMES
    Santos, São Paulo, Brazil
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.